Physician profile
Jason A Chin
NPI 1710245931
$5,766.61
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,073 · 2020: $369 · 2021: $91.23 · 2022: $963 · 2023: $2,646 · 2024: $624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,683 · Food and Beverage: $1,587.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,683.16 |
| Food and Beverage | $1,586.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $3,062.86 | 2019-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cook Medical LLC | $743.20 | 2022-2023 | Zenith, Zenith Spiral-Z |
| Medtronic Vascular, INC. | $725.33 | 2019-2020 | |
| Medtronic, INC. | $382.73 | 2021-2024 | Endurant Iis, Hawkone, In.Pact Av |
| Boston Scientific Corporation | $203.38 | 2022-2024 | Ekosonic, Eluvia, Angiojet Ultra 5000a |
| Bolton Medical INC | $128.33 | 2024 | Treo Abdominal Stent-Graft System |
| Cardinal Health 200 LLC | $101.47 | 2019 | |
| Bard Peripheral Vascular, INC. | $96.33 | 2019 | |
| Penumbra, INC. | $73.08 | 2021 | |
| Abbott Laboratories | $51.70 | 2022-2023 | Amplatzer Amulet |
| Pfizer INC. | $39.69 | 2020 | |
| Janssen Pharmaceuticals, INC | $33.32 | 2020-2022 | |
| Abiomed | $31.71 | 2024 | Impella |
| United Therapeutics Corporation | $29.95 | 2024 | Remodulin, Orenitram |
| Edwards Lifesciences Corporation | $26.10 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $20.11 | 2022 | |
| Tactile Systems Technology INC | $17.32 | 2024 | Entre Plus, Flexitouch Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Chin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.